Therapies / Research / Gene Therapy / Gene / Cancer / Biopharma / Genes / BioPharma / Biotech / BioTech / Boston blog main / Boston top stories / Boulder / Denver blog main / Denver top stories / Detroit blog main / Detroit top stories / Indiana blog main / Indiana top stories / National / National blog main / National top stories / New York blog main / New York top stories / Raleigh-Durham blog main / Raleigh-Durham top stories / San Diego blog main / San Diego top stories / San Francisco blog main / San Francisco top stories / Seattle blog main / Seattle top stories / Texas blog main / Texas top stories / Wisconsin blog main / Wisconsin top stories / Adynxx / Alexion Pharmaceuticals / AstraZeneca / atezolizumab / AveXis / Axovant Sciences / Biogen / Bristol-myers Squibb / CAR-T / Cellectis / Constellation Pharmaceuticals / Cubist / David Hung / deals / Elizabeth Holmes / epacadostat / GlaxoSmithKline / Illumina / Immunotherapy / Incyte / Ionis Pharmaceuticals / Keytruda / Kite Pharma / Life Sciences / Loxo Oncology / Lung Cancer / Menlo Therapeutics / Merck / Novartis / Orchard Therapeutics / PD-L1 / pembrolizumab / Roche / Roundups / Spinal Muscular Atrophy / Tecentriq / Theranos / Unity Biotechnology / Valeant Pharmaceuticals / VeraCyte / vTv Therapeutics / Wilson Therapeutics

Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts

Posted on: Apr 13, 2018   |   Posted by: Biotech Mag Top

Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts

This weekend, cancer immunotherapy will once again take biopharma's center stage. At one of the year's big cancer meetings, investors, researchers, and many others will have a...

Continue reading ...



Other Posts from Biotech Mag Top